DBV Technologies (NASDAQ:DBVT) received a $57.00 price target from analysts at Citigroup in a report issued on Wednesday. The firm currently has a “buy” rating on the stock. Citigroup’s target price would suggest a potential upside of 117.31% from the stock’s current price.

A number of other brokerages have also commented on DBVT. BidaskClub upgraded shares of DBV Technologies from a “hold” rating to a “buy” rating in a research note on Thursday, January 11th. Leerink Swann set a $49.00 price target on shares of DBV Technologies and gave the stock an “outperform” rating in a research note on Monday, October 23rd. Morgan Stanley lowered shares of DBV Technologies from an “overweight” rating to an “equal weight” rating in a research note on Monday, October 23rd. Zacks Investment Research lowered shares of DBV Technologies from a “hold” rating to a “sell” rating in a research note on Monday, December 25th. Finally, HC Wainwright reiterated a “buy” rating and issued a $50.00 price target on shares of DBV Technologies in a research note on Monday, October 23rd. Three research analysts have rated the stock with a sell rating, two have issued a hold rating and eight have assigned a buy rating to the company. DBV Technologies currently has a consensus rating of “Hold” and a consensus price target of $49.63.

Shares of DBV Technologies (DBVT) opened at $26.23 on Wednesday. DBV Technologies has a 12 month low of $20.08 and a 12 month high of $50.57.

Several institutional investors and hedge funds have recently bought and sold shares of the stock. Jane Street Group LLC boosted its holdings in shares of DBV Technologies by 21.3% in the fourth quarter. Jane Street Group LLC now owns 195,967 shares of the company’s stock worth $4,924,000 after buying an additional 34,355 shares during the last quarter. OLD Mission Capital LLC boosted its holdings in shares of DBV Technologies by 498.5% in the fourth quarter. OLD Mission Capital LLC now owns 50,875 shares of the company’s stock worth $1,252,000 after buying an additional 42,374 shares during the last quarter. Perceptive Advisors LLC boosted its holdings in shares of DBV Technologies by 3,604.2% in the fourth quarter. Perceptive Advisors LLC now owns 978,619 shares of the company’s stock worth $24,075,000 after buying an additional 952,200 shares during the last quarter. ArrowMark Colorado Holdings LLC boosted its holdings in shares of DBV Technologies by 94.9% in the fourth quarter. ArrowMark Colorado Holdings LLC now owns 2,007,684 shares of the company’s stock worth $49,389,000 after buying an additional 977,491 shares during the last quarter. Finally, University of Notre Dame DU Lac boosted its holdings in shares of DBV Technologies by 94.3% in the fourth quarter. University of Notre Dame DU Lac now owns 115,115 shares of the company’s stock worth $2,832,000 after buying an additional 55,860 shares during the last quarter. 46.36% of the stock is currently owned by institutional investors.

WARNING: “DBV Technologies (DBVT) PT Set at $57.00 by Citigroup” was first reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this piece of content on another publication, it was illegally stolen and reposted in violation of United States & international trademark and copyright laws. The legal version of this piece of content can be viewed at https://www.thecerbatgem.com/2018/02/15/dbv-technologies-dbvt-pt-set-at-57-00-by-citigroup.html.

DBV Technologies Company Profile

DBV Technologies SA is a France-based clinical-stage biopharmaceutical company focused on changing the field of immunotherapy by developing a technology platform called Vaskin. The Company’s therapeutic approach is based on epicutaneous immunotherapy, or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin.

Analyst Recommendations for DBV Technologies (NASDAQ:DBVT)

Receive News & Ratings for DBV Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DBV Technologies and related companies with MarketBeat.com's FREE daily email newsletter.